US2005269722A1PendingUtilityA1
Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
Est. expiryJul 17, 2022(expired)· nominal 20-yr term from priority
A61P 7/10A61P 25/24A61P 11/08B01J 13/08B01J 13/06A61K 9/5073
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Process for the production of microcapsules containing a drug and comprising a layer of ethylcellulose and a layer of an acrylic polymer and microcapsules produced thereby.
Claims
exact text as granted — not AI-modified1 . A process for the production of microcapsules containing a drug, comprising the following steps:
a. coating drug microparticles with a layer of ethylcellulose b. further coating the product of a. with a layer of an acrylic polymer.
2 . A process according to claim 1 , where the coating in step a. is applied by phase separation microencapsulation or by fluidized bed coating.
3 . A process according to claim 1 , wherein the coating in step b. is applied by spraying a solution of suspension of acrylic polymer onto the particles obtained in a., suspended in a fluidized bed.
4 . A process according to claim 3 , wherein said solution or suspension is a hydroalcoholic solution, comprising the following weight percentages of components, calculated with respect to the total weight of the solution:
acrylic polymer: 4-20% alcohol: 30-94% water: 0-40% micronised inorganic material: 2-20%
5 . A process according to claim 3 , wherein said hydroalcoholic solution or suspension comprises the following weight percentages of components, calculated with respect to the total weight of the solution:
acrylic polymer: 7-20% alcohol: 40-75% water: 10-35% micronised inorganic material: 5-9%
6 . A process according to claim 4 , wherein said alcohol is ethanol, and said inorganic material is talc.
7 . A process according to claim 1 , wherein the product of step a. has a drug/ethylcellulose weight ratio (phase ratio) comprised between 1:1 and 30:1, and the product of step b. has an acrylic polymer content comprised between 5% and 40% by weight.
8 . A process according to claim 1 , wherein the product of step a. has a drug/ethylcellulose weight ratio (phase ratio) comprised between 3:1 and 15:1, and the product of step b. has an acrylic polymer content comprised between 10% and 25% by weight.
9 . A process according to claim 1 , wherein the taste-masked microcapsules obtained in step b. have a weight median diameter comprised between 20 and 800 μm, drug potency comprised between 400 and 950 mg/g, and are capable of releasing at least 80% of the drug contained therein within 30 minutes in a aqueous acidic media.
10 . Microcapsules containing a drug, obtainable by the process described in claim 1 .
11 . Microcapsules according to claim 10 , formulated in a pharmaceutical administrable form.
12 . Microcapsules according to claim 11 , wherein said pharmaceutical administrable form is chosen from dry powders for extemporaneous suspensions, tablets, minitablets, microcapsule-containing capsules, monodose sachets, fast disintegrating tables, syrups.
13 . Microcapsules according to claim 10 , wherein said drug is chosen from penicillins, cephalosporins, carbapenem, penems, penams, aminoglycosides, macrolides, ketolides, tetracyclines, quinolones.
14 . A process according to claim 9 wherein the taste-masked microcapsules obtained in step b. have a weight median diameter comprised between 100 and 400 μM and a drug potency comprised between 400 and 950 mg/g.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.